Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2025-12-17 @ 4:09 PM
Study NCT ID:
NCT06199427
Status:
None
Last Update Posted:
2024-01-10 00:00:00
First Post:
2023-12-28 00:00:00
Brief Title:
PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity
Sponsor:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Organization:
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Organization Data
Organization:
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Class:
OTHER
Study ID:
IEI-PTCy 2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None